Immunome Inc. (IMNM) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Immunome Inc.

    NASDAQ: IMNM · Real-Time Price · USD
    10.52
    0.72 (7.35%)
    At close: Sep 05, 2025, 3:59 PM
    10.58
    0.57%
    After-hours: Sep 05, 2025, 07:42 PM EDT

    Immunome Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 9.04M 14.02M n/a n/a
    Cost of Revenue
    		 n/a 728K 631K 755K
    Gross Profit
    		 9.04M 14.02M -631K -755K
    Operating Income
    		 -305.8M -109.53M -36.9M -25.2M
    Interest Income
    		 12.84M 2.72M 5K 10K
    Pretax Income
    		 -292.96M -106.81M -36.9M -24.71M
    Net Income
    		 -292.96M -106.81M -37.51M -24.71M
    Selling & General & Admin
    		 32.95M 19.66M 13.63M 11.09M
    Research & Development
    		 129.54M 23.09M 23.27M 14.11M
    Other Expenses
    		 152.34M 80.8M -631K n/a
    Operating Expenses
    		 314.84M 123.55M 36.27M 25.2M
    Interest Expense
    		 n/a n/a 5K 10K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 314.84M 123.55M 36.9M 25.2M
    Income Tax Expense
    		 n/a n/a 617K n/a
    Shares Outstanding (Basic)
    		 58.64M 19.84M 12.13M 11.54M
    Shares Outstanding (Diluted)
    		 58.64M 19.84M 12.13M 11.54M
    EPS (Basic)
    		 -5 -5.38 -3.09 -2.14
    EPS (Diluted)
    		 -5 -5.38 -3.09 -2.14
    EBITDA
    		 -151.35M -28M -36.27M -23.95M
    EBIT
    		 -153.46M -28.73M -36.9M -24.7M
    Depreciation & Amortization
    		 2.1M 728K 631K 755K

    Add to Watchlist